Life Sciences
Latest Content
Phase 2 trials underway for new pneumococcal disease vaccine
Trials are underway on a £3.2 million-funded new vaccine to tackle the presence pneumococcal disease, a leading preventable cause of child deaths.
News
Phase 2 trials underway for new pneumococcal disease vaccine
Trials are underway on a £3.2 million-funded new vaccine to tackle the presence pneumococcal disease, a leading preventable cause of child deaths.
In Depth
Innovation in dialysis equipment
In 2022, more than 30,000 people were undergoing kidney dialysis in the UK [1], all of whom will require precision machinery, either at home or in a dialysis centre, to remove metabolites and toxins …
Comment And Analysis
Study reveals the eye is the window to the heart
Routine eye scans could help identify major coronary illness up to a decade early, concludes research supported by two leading health organisations.
Interviews
Evolving prostate cancer research with FFPE samples
Dr. Nallasivam Palanisamy of the Henry Ford Health System and Michigan State University and Dr. Han Wei of Beckman Coulter Life Sciences, who have been collaborating, together with their respective t…
